Therapeutic Areas
Advancing Neuroscience Research
We understand that developing drugs for neuroscience indications can be challenging. We utilize an integrated service package to provide appropriate solutions to solve common issues in this field of research.
Axcelead focuses on targeting biological pathways associated with drivers of neurological disease.
When you partner with us, we will validate the scientific hypothesis of hitting a particular target based on the change of gene and protein expression using iPSC, patient-derived CSF, plasma and brain cells. Further, we will evaluate the potential of your compound using various measures of brain function and efficacy with behavioral tests specific to the development of neuroscience drugs.